tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2022 Aug 3;9(8)
fac389.
doi: 10.1093/ofid/ofac389. eCollection 2022 Aug.
Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
Sarah Lim[SUP] 1 [/SUP], Christopher J Tignanelli[SUP] 2 [/SUP], Nicolas Hoertel[SUP] 3 [/SUP], David R Boulware[SUP] 4 [/SUP], Michael G Usher[SUP] 4 [/SUP]
Affiliations
Abstract
This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness.
Keywords: COVID-19; Palovid; contraindications; nirmatrelvir/ritonavir.
. 2022 Aug 3;9(8)
fac389.doi: 10.1093/ofid/ofac389. eCollection 2022 Aug.
Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19
Sarah Lim[SUP] 1 [/SUP], Christopher J Tignanelli[SUP] 2 [/SUP], Nicolas Hoertel[SUP] 3 [/SUP], David R Boulware[SUP] 4 [/SUP], Michael G Usher[SUP] 4 [/SUP]
Affiliations
- PMID: 36000003
- PMCID: PMC9384640
- DOI: 10.1093/ofid/ofac389
Abstract
This analysis describes the prevalence of contraindications to nirmatrelvir/ritonavir among 66 007 patients with coronavirus disease 2019 in a large health care system. A possible contradiction was present in 9830 patients (14.8%), with the prevalence of contraindications increasing with higher acuity of illness.
Keywords: COVID-19; Palovid; contraindications; nirmatrelvir/ritonavir.